You are required to be logged in to access the full website
Click here if you have forgotten your username or password
18 November 2026 - DDL, a third-party testing laboratory specialising in medical device and pharmaceutical packaging, combination products, and materials testing, announced on Tuesday that it has launched a new Pharmaceutical Consulting Services prog...
18 November 2026 - Ichnos Glenmark Innovation Inc (IGI), a clinical-stage biotechnology company focused on developing Multispecific therapeutics in oncology, announced on Tuesday the submission of an Investigational New Drug (IND) application to the ...
18 November 2026 - Inhibrx Biosciences Inc (Nasdaq:INBX), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, announced on Tuesday updated clinical data from the Phase 1/2 expansion study evaluating...
18 November 2026 - Clinical-stage oncology company Onward Therapeutics Inc announced on Tuesday that it has closed its Series B financing of NTD900m (approximately USD28m).The round was raised in two closings, the second of which took place in Octobe...
18 November 2026 - Chinese biopharmaceutical company Harbour BioMed (HKEX:02142) announced on Tuesday that its partner Spruce Biosciences (Nasdaq:SPRB) has separated its CRHX-101 (formerly SPR-202 and HBM9013) programme into Adrenyx Biosciences.Adren...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe